Harry Ritchie, PhD, Director of Business and Market Development at Advanced Materials Technology, shares how crucial sustainability has become in the field of chromatography, and provides helpful ...

At HPLC 2025 in Bruges, Belgium LCGC International interviewed a member of our editorial advisory board (EAB), Paul Ferguson, ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

Top science stories featured on ScienceDaily's home page.